[{"Assets_0_Q3_USD":8823700000.0,"CommonStockSharesOutstanding_0_Q3_shares":372999206.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":97800000.0,"NetIncomeLoss_1_Q3_USD":10000000.0,"NetIncomeLoss_3_Q3_USD":77400000.0,"StockholdersEquity_0_Q3_USD":5487700000.0,"EarningsPerShareBasic_1_Q3_USD":0.03,"EarningsPerShareBasic_3_Q3_USD":0.21,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":371600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":367700000.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20191108"}]